BioAmber launches public offering of common stock

Canaccord and Barclays are bookrunners; deal includes 15% greenshoe

By Marisa Wong

Madison, Wis., April 30 – BioAmber Inc. said it has begun an underwritten public offering of common stock.

The company has also granting the underwriters a 30-day option to purchase up to an additional 15% of the shares offered.

Canaccord Genuity Inc. and Barclays Capital Inc. are the joint bookrunners for the offering. Raymond James & Associates, Inc. and SG Americas Securities, LLC are acting as co-managers.

BioAmber is an industrial biotechnology company based in Minneapolis.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.